Diğer Kripto Paralara Git
INCYIncyte Corporation
Incyte Corporation
INCYAna Çıkarımlar
Son güncelleme:: 2026-06-08- •Incyte, nadir kanama bozukluklarını hedefleyerek ve JAK inhibitörü gelir yoğunluğundan çeşitlendirme yaparak Vega Therapeutics için 1,25 milyar dolar ödüyor.
- •Anlaşma aşaması (preklinik mi yoksa Faz 2+ mı) anahtar değişkendir — açıklanan daha fazla klinik veri, INCY'nin yukarı veya aşağı yeniden fiyatlandırılıp fiyatlandırılmayacağını doğrudan belirleyecektir.
- •INCY şu anda 97,07 dolardan işlem görüyor; satış tarafı analistleri EPS ve Ar-Ge harcama tahminlerini revize ettikçe artan zımni oynaklık bekleniyor.
- •SMID-cap hematoloji ve nadir hastalık biyoteknolojisi benzerleri, M&A taban değerlemeleri onaylandıkça dolaylı olarak fayda sağlıyor.
- •Bu anlaşma, Star Therapeutics kuluçka modelini doğruluyor ve platform odaklı biyoteknoloji oluşturma stratejilerine benzer şekilde VC yatırımını hızlandırabilir.
Fiyat & Piyasa Yapısı
Ticaret Rejimi Durumu
Glossary
Key listed-stock and CFD terms, one line each — so the page is unambiguous for both readers and AI answer engines.
| Stock CFD | A contract for difference on a share price — price exposure only, not ownership of the underlying shares. |
|---|---|
| Extended hours | Pre-market and after-hours trading outside the exchange’s regular session. |
| Basis risk | The risk that the CFD reference price and the exchange execution price do not move in step. |
| P/E | Price-to-earnings ratio = share price ÷ earnings per share; a common valuation gauge. |
| Gross margin | Gross profit ÷ revenue; reflects product-level profitability. |
| EPS | Earnings per share = net income ÷ diluted shares outstanding. |
Son Pulslar
Incyte, Vega Therapeutics'u 1,25 Milyar Dolara Satın Aldı — Hematoloji Bahsi Büyütüyor Biyoteknoloji M&A Dalgasını
Incyte Corporation (NASDAQ: INCY), Star Therapeutics şirket oluşturma platformu bünyesinde geliştirilen özel sermayeli, hematoloji odaklı bir biyoteknoloji şirketi olan Vega Therapeutics'i 1,25 milyar
Incyte'nin Yaklaşık 2 Milyar Dolarlık Star Therapeutics Anlaşması: Kaldıraç Senaryoları ve Biyoteknoloji M&A Okuması
Financial Times'ın bildirdiğine göre, Incyte Corporation (INCY), özel bir kan hastalığı ilacı geliştiricisi olan Star Therapeutics'i yaklaşık 2 milyar dolarlık bir anlaşmayla satın almak üzere. Anlaşm
Get Started with Incyte Corporation
Start trading Incyte Corporation on CoinUnited.io with industry-leading leverage and zero fees.
Trade with Leverage
Trade INCY CFDs with up to 1000x leverage on CoinUnited.io.
- Up to 1000x leverage
- Zero trading fees
- Advanced risk management tools
Explore Stocks
Browse the full stocks market on CoinUnited.io with 125+ instruments.
- 125+ stocks instruments
- Real-time market data
- Professional charting tools
Learn Stocks Trading
Read our in-depth research and analysis on stocks markets.
- Expert market analysis
- Technical analysis basics
- Daily market insights
How to Trade Incyte Corporation: Step-by-Step Guide
Learn how to trade Incyte Corporation (INCY) on CoinUnited.io with up to 1000x leverageand zero trading fees. Follow this simple step-by-step guide to start CFD trading today.
Create Your CoinUnited.io Account
Sign up at CoinUnited.io in under a minute. You'll need an email address to get started.
- ✓Quick and free registration
- ✓Email and password setup
- ✓Two-factor authentication for security
Verify Your Identity
Complete the KYC verification process to unlock full trading features and higher limits.
- ✓Upload government-issued ID
- ✓Proof of address document
- ✓Usually verified within minutes
Deposit Funds
Fund your account using one of the supported deposit methods.
Deposit Methods
- •Cryptocurrency deposits (BTC, ETH, USDT)
- •Bank transfer available
- •No minimum deposit requirement
Find INCY in the Stocks Section
Navigate to the stocks market section and search for INCY. You can trade Incyte Corporation as a CFD with up to 1000x leverage.
- ✓Search for "INCY" in the trading platform
- ✓Select CFD trading mode
- ✓Review the current price and market data
Place Your Trade
Choose your position direction (long or short), set your leverage, and enter your position size to trade Incyte Corporation.
- ✓Long (buy) if you expect INCY to rise
- ✓Short (sell) if you expect INCY to fall
- ✓Set stop-loss and take-profit levels
Monitor & Manage Risk
Keep track of your open positions and manage risk with stop-loss orders and position sizing.
- ✓Monitor P&L in real-time
- ✓Adjust stop-loss as needed
- ✓Never risk more than you can afford to lose
Order Types
Market Order
Execute immediately at the current market price. Best for quick entries.
Limit Order
Set a specific price to enter. The order fills only when the market reaches your price.
Stop-Loss Order
Automatically close your position at a specified price to limit potential losses.
Important Tips
- • Start with a small position to understand how leverage works
- • Always set a stop-loss to protect your capital
- • Higher leverage amplifies both gains and losses
- • Never invest more than you can afford to lose
Incyte Corporation ile İşlem Yapmaya Hazır Mısınız?
1000x'e kadar kaldıraç · 7/24 ticaret
INCY ile İşlem Yapmaya BaşlayınEtiketler
Similar Stocks Assets
Explore other stocks instruments in the same sector as Incyte Corporation. Compare performance and find trading opportunities.

Tempus AI, Inc

Estee Lauder

Hecla Mining Company

Coeur Mining, Inc.

Kinross Gold Corporation
Feragatnameler & Referanslar
Önemli Risk Uyarısı
A CoinUnited stock CFD gives price exposure to Incyte Corporation only, not equity ownership: no shareholder voting rights, no dividends, and no settlement in the underlying share.
Leverage magnifies losses as well as gains, and a position can be liquidated long before the underlying share price recovers. The underlying listing trades on exchange hours, so the reference price can gap between sessions.
Kullanıcıların, herhangi bir yatırım kararı almadan önce kendi araştırmalarını yapmaları ve nitelikli finans profesyonellerine danışmaları önerilir. Bu platformun oluşturucuları ve işletmecileri, sağlanan bilgilere dayanarak oluşabilecek herhangi bir finansal kayıp veya diğer zararlar için hiçbir sorumluluk kabul etmezler.
Leveraged trading is extremely risky and you may lose your entire deposit.
Metodoloji Genel Bakış
Figures on this page are compiled from primary and named third-party sources, not produced by a forecasting model. Each one carries its source and date in the Source Map above.
- Financial statements: the company’s own SEC filings (10-K / 10-Q), read from XBRL
- Market data: the CoinUnited reference price and daily closes
- Institutional ownership: SEC Form 13F quarterly filings
- Analyst targets: aggregated third-party sell-side coverage — third-party opinion, not CoinUnited’s view
- Peer multiples: third-party trailing-twelve-month ratios
CoinUnited does not publish a price forecast or target for Incyte Corporation.
Son metodoloji gözden geçirmesi:
Incyte Corporation Ticaretine Başlamaya Hazır Mısınız?
Binlerce tüccara katılın ve Incyte Corporation ticaret yolculuğunuza bugün başlayın. Gelişmiş ticaret araçlarına ve rekabetçi ücretlere erişim elde edin.



